<DOC>
	<DOCNO>NCT01771809</DOCNO>
	<brief_summary>Subjects Ulcerative Colitis complete induction study PF-00547659 receive additional 144 week open-label treatment evaluate long-term safety drug .</brief_summary>
	<brief_title>Long-Term Safety Of PF-00547659 In Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Subjects 18 66 year age . Subjects previously enrol study A7281009 ( NCT01620255 ) complete 84 day ( 12 week ) induction period . Subjects complete Day 84 ( Week 12 ) study A7281009 experience serious event ( ) relate investigational product , unstable medical condition , reason , opinion investigator , would preclude entry participation study . Subjects take dose Azathioprine ( AZA ) , 6mercaptopurine ( 6 MP ) Methotrexate ( MTX ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Anti-TNF Refractory</keyword>
	<keyword>Immunosuppressant Refractory</keyword>
	<keyword>Active Ulcerative Colitis</keyword>
</DOC>